Table 2.
Baseline CRP concentration and change in CRP are not associated with recurrence of preeclampsia
Preeclampsia (n=50) | Controls (n=205) | |||
---|---|---|---|---|
Median (range) | Median (range) | OR (95% CI) ## | Adjusted OR (95% CI) ## | |
Baseline CRP (mg/dL) | 1.17 (0.09, 5.72) | 1.01 (0.01, 4.97) | 1.000 (1.000, 1.000) | 1.0 (1.000, 1.000)* |
CRP closest to delivery (mg/dL) | 0.71 (0.06, 2.94) | 0.76 (0.01, 4.62) | ||
Change in CRP (mg/dL) | −0.02 (−0.22, 0.30) | −0.02 (−0.43, 0.05) | 0.996 (0.992, 1.001) | 0.993 (0.986, 1.000)# |
Controlling for BMI, gestational age at baseline sample collection, race, age, and smoking status.
Controlling for BMI, gestational age at baseline sample collection, race, age, smoking status, baseline CRP concentration and aspirin treatment.
Odds ratio represents an increase in odds for each μg/dl increase in CRP.